Next-generation vaccines could make the flu season less of a snot-filled nightmare—if they ever reach the public, that is. Trial data out this week shows that Pfizer’s mRNA-based flu vaccine performed markedly better than a…
Continue Reading
News Source: gizmodo.com

Leave a Reply